» Articles » PMID: 36347996

GDF11 Promotes Wound Healing in Diabetic Mice Via Stimulating HIF-1ɑ-VEGF/SDF-1ɑ-mediated Endothelial Progenitor Cell Mobilization and Neovascularization

Abstract

Non-healing diabetic wounds (DW) are a serious clinical problem that remained poorly understood. We recently found that topical application of growth differentiation factor 11 (GDF11) accelerated skin wound healing in both Type 1 DM (T1DM) and genetically engineered Type 2 diabetic db/db (T2DM) mice. In the present study, we elucidated the cellular and molecular mechanisms underlying the action of GDF11 on healing of small skin wound. Single round-shape full-thickness wound of 5-mm diameter with muscle and bone exposed was made on mouse dorsum using a sterile punch biopsy 7 days following the onset of DM. Recombinant human GDF11 (rGDF11, 50 ng/mL, 10 μL) was topically applied onto the wound area twice a day until epidermal closure (maximum 14 days). Digital images of wound were obtained once a day from D0 to D14 post-wounding. We showed that topical application of GDF11 accelerated the healing of full-thickness skin wounds in both type 1 and type 2 diabetic mice, even after GDF8 (a muscle growth factor) had been silenced. At the cellular level, GDF11 significantly facilitated neovascularization to enhance regeneration of skin tissues by stimulating mobilization, migration and homing of endothelial progenitor cells (EPCs) to the wounded area. At the molecular level, GDF11 greatly increased HIF-1ɑ expression to enhance the activities of VEGF and SDF-1ɑ, thereby neovascularization. We found that endogenous GDF11 level was robustly decreased in skin tissue of diabetic wounds. The specific antibody against GDF11 or silence of GDF11 by siRNA in healthy mice mimicked the non-healing property of diabetic wound. Thus, we demonstrate that GDF11 promotes diabetic wound healing via stimulating endothelial progenitor cells mobilization and neovascularization mediated by HIF-1ɑ-VEGF/SDF-1ɑ pathway. Our results support the potential of GDF11 as a therapeutic agent for non-healing DW.

Citing Articles

Gentiopicroside targeting AKT1 activates HIF-1α/VEGF axis promoting diabetic ulcer wound healing.

Wang X, Liu M, Wu Y, Sun J, Liu L, Pan Z Front Pharmacol. 2025; 16:1506499.

PMID: 40078292 PMC: 11897484. DOI: 10.3389/fphar.2025.1506499.


Polyethylene Glycol Loxenatide Accelerates Diabetic Wound Healing by Downregulating Systemic Inflammation and Improving Endothelial Progenitor Cell Functions.

Ding Z, Yang C, Zhai X, Xia Y, Liu J, Yu M Int J Mol Sci. 2025; 26(5).

PMID: 40076985 PMC: 11901084. DOI: 10.3390/ijms26052367.


KLF5 enhances CXCL12 transcription in adipose-derived stem cells to promote endothelial progenitor cells neovascularization and accelerate diabetic wound healing.

Xie Y, Ni X, Wan X, Xu N, Chen L, Lin C Cell Mol Biol Lett. 2025; 30(1):24.

PMID: 40038579 PMC: 11877965. DOI: 10.1186/s11658-025-00702-0.


Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity.

Huang K, Mi B, Xiong Y, Fu Z, Zhou W, Liu W Burns Trauma. 2025; 13:tkae052.

PMID: 39927093 PMC: 11802347. DOI: 10.1093/burnst/tkae052.


Dandelion-shaped strontium-gallium microparticles for the hierarchical stimulation and comprehensive regulation of wound healing.

Ji M, Yuan Z, Ma H, Feng X, Ye C, Shi L Regen Biomater. 2024; 11:rbae121.

PMID: 39544394 PMC: 11561401. DOI: 10.1093/rb/rbae121.


References
1.
ROBSON M, PHILLIPS L, Thomason A, Robson L, Pierce G . Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 1992; 339(8784):23-5. DOI: 10.1016/0140-6736(92)90143-q. View

2.
Robbins J, Strauss G, Aron D, Long J, Kuba J, Kaplan Y . Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?. J Am Podiatr Med Assoc. 2008; 98(6):489-93. DOI: 10.7547/0980489. View

3.
Shen Y, Guo Y, Mikus P, Sulniute R, Wilczynska M, Ny T . Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood. 2012; 119(24):5879-87. DOI: 10.1182/blood-2012-01-407825. View

4.
Rana D, Kumar A, Sharma S . Endothelial Progenitor Cells as Molecular Targets in Vascular Senescence and Repair. Curr Stem Cell Res Ther. 2018; 13(6):438-446. DOI: 10.2174/1574888X13666180502100620. View

5.
Hiesinger W, Perez-Aguilar J, Atluri P, Marotta N, Frederick J, Fitzpatrick 3rd J . Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog. Circulation. 2011; 124(11 Suppl):S18-26. PMC: 4136555. DOI: 10.1161/CIRCULATIONAHA.110.009431. View